Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

Progression to end-stage liver disease in patients with inherited bleeding disorders and hepatitis C: an international, multicenter cohort study.

Posthouwer D, Makris M, Yee TT, Fischer K, van Veen JJ, Griffioen A, van Erpecum KJ, Mauser-Bunschoten EP.

Blood. 2007 May 1;109(9):3667-71. Epub 2007 Jan 9.

2.

End-stage liver disease in persons with hemophilia and transfusion-associated infections.

Goedert JJ, Eyster ME, Lederman MM, Mandalaki T, De Moerloose P, White GC 2nd, Angiolillo AL, Luban NL, Sherman KE, Manco-Johnson M, Preiss L, Leissinger C, Kessler CM, Cohen AR, DiMichele D, Hilgartner MW, Aledort LM, Kroner BL, Rosenberg PS, Hatzakis A.

Blood. 2002 Sep 1;100(5):1584-9.

3.

Lack of association of hepatitis C virus load and genotype with risk of end-stage liver disease in patients with human immunodeficiency virus coinfection.

Goedert JJ, Hatzakis A, Sherman KE, Eyster ME; Multicenter Hemophilia Cohort Study.

J Infect Dis. 2001 Nov 1;184(9):1202-5. Epub 2001 Sep 13.

PMID:
11598846
4.

HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis.

Pineda JA, Romero-Gómez M, Díaz-García F, Girón-González JA, Montero JL, Torre-Cisneros J, Andrade RJ, González-Serrano M, Aguilar J, Aguilar-Guisado M, Navarro JM, Salmerón J, Caballero-Granado FJ, García-García JA; Grupo Andaluz para el Estudio de las Enfermedades Infecciosas; Grupo Andaluz para el Estudio del Hígado.

Hepatology. 2005 Apr;41(4):779-89.

PMID:
15800956
5.

The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985.

Yee TT, Griffioen A, Sabin CA, Dusheiko G, Lee CA.

Gut. 2000 Dec;47(6):845-51.

6.

The natural history of childhood-acquired hepatitis C infection in patients with inherited bleeding disorders.

Posthouwer D, Fischer K, van Erpecum KJ, Mauser-Bunschoten EP.

Transfusion. 2006 Aug;46(8):1360-6.

PMID:
16934072
7.

Determinants of progression of HIV infection in a Greek hemophilia cohort followed for up to 16 years after seroconversion.

Touloumi G, Karafoulidou A, Gialeraki A, Katsarou O, Milona I, Kapsimali V, Mandalaki T, Hatzakis A.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Sep 1;19(1):89-97.

PMID:
9732075
8.

Adverse outcomes in Alaska natives who recovered from or have chronic hepatitis C infection.

McMahon BJ, Bruden D, Bruce MG, Livingston S, Christensen C, Homan C, Hennessy TW, Williams J, Sullivan D, Rosen HR, Gretch D.

Gastroenterology. 2010 Mar;138(3):922-31.e1. doi: 10.1053/j.gastro.2009.10.056. Epub 2009 Nov 10.

PMID:
19909749
9.

Antiviral therapy for chronic hepatitis C in patients with inherited bleeding disorders: an international, multicenter cohort study.

Posthouwer D, Yee TT, Makris M, Fischer K, Griffioen A, Van Veen JJ, Mauser-Bunschoten EP.

J Thromb Haemost. 2007 Aug;5(8):1624-9.

10.

HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3.

Borghi V, Puoti M, Mussini C, Bellelli S, Angeletti C, Sabbatini F, Prati F, Cossarizza A, Esposito R.

Antivir Ther. 2008;13(8):1057-65.

PMID:
19195331
11.

Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease.

Merchante N, Girón-González JA, González-Serrano M, Torre-Cisneros J, García-García JA, Arizcorreta A, Ruiz-Morales J, Cano-Lliteras P, Lozano F, Martínez-Sierra C, Macías J, Pineda JA; Grupo Andaluz para el Estudio de las Enfermedades Infecciosas.

AIDS. 2006 Jan 2;20(1):49-57.

PMID:
16327319
12.

Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis.

d'Arminio Monforte A, Cozzi-Lepri A, Castagna A, Antinori A, De Luca A, Mussini C, Caputo SL, Arlotti M, Magnani G, Pellizzer G, Maggiolo F, Puoti M; Icona Foundation Study Group.

Clin Infect Dis. 2009 Aug 15;49(4):612-22. doi: 10.1086/603557.

PMID:
19591597
13.

Long-term follow-up of hepatitis C infection in a large cohort of patients with inherited bleeding disorders.

Fransen van de Putte DE, Makris M, Fischer K, Yee TT, Kirk L, van Erpecum KJ, Patch D, Posthouwer D, Mauser-Bunschoten EP.

J Hepatol. 2014 Jan;60(1):39-45. doi: 10.1016/j.jhep.2013.08.010. Epub 2013 Aug 23.

PMID:
23978717
14.

Progression of HIV infection and mortality by hepatitis C infection in patients with haemophilia over 20 years.

Quintana M, del Amo J, Barrasa A, Pérez-Hoyos S, Ferreros I, Hernández F, Villar A, Jiménez V, Bolúmar F.

Haemophilia. 2003 Sep;9(5):605-12.

PMID:
14511302
15.

Risk of hepatitis-related mortality increased among hepatitis C virus/HIV-coinfected drug users compared with drug users infected only with hepatitis C virus: a 20-year prospective study.

Smit C, van den Berg C, Geskus R, Berkhout B, Coutinho R, Prins M.

J Acquir Immune Defic Syndr. 2008 Feb 1;47(2):221-5. doi: 10.1097/QAI.0b013e31815d2f59.

PMID:
18223361
16.

The association between hepatitis C virus genotype and human immunodeficiency virus disease progression in a cohort of hemophilic men.

Sabin CA, Telfer P, Phillips AN, Bhagani S, Lee CA.

J Infect Dis. 1997 Jan;175(1):164-8.

PMID:
8985212
17.

HCV quasispecies evolution: association with progression to end-stage liver disease in hemophiliacs infected with HCV or HCV/HIV.

Qin H, Shire NJ, Keenan ED, Rouster SD, Eyster ME, Goedert JJ, Koziel MJ, Sherman KE; Multicenter Hemophilia Cohort Study Group.

Blood. 2005 Jan 15;105(2):533-41. Epub 2004 Sep 16.

18.
19.
20.

The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.

Murillas J, Rimola A, Laguno M, de Lazzari E, Rascón J, Agüero F, Blanco JL, Moitinho E, Moreno A, Miró JM; ESLD-HIV Working Group Investigators.

Liver Transpl. 2009 Sep;15(9):1133-41. doi: 10.1002/lt.21735.

Supplemental Content

Support Center